The British Journal of Rheumatology, Vol 37, 908-911, Copyright © 1998 by British Society for Rheumatology
S Wassenberg, G Herborn and R Rau
Felty's syndrome is a rare disorder characterized as a systemic
manifestation of severe rheumatoid arthritis associated with
granulocytopenia and splenomegaly. We report a retrospective analysis of a
series of seven patients treated successfully with low-dose methotrexate.
leading to sustained clinical improvement (number of swollen joints) and
normalization of the granulocyte count for an observation period of 1 yr.
Our cohort is the largest ever published with methotrexate treatment of
this rare condition. Our results confirm earlier single case reports
suggesting methotrexate to be the first- choice treatment nowadays in
Felty's syndrome.
ORIGINAL PAPERS
Methotrexate treatment in Felty's syndrome
Department of Rheumatology, Evangelisches Fachkrankenhaus, Ratingen, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Mahevas, S. Audia, V. De Lastours, M. Michel, B. Bonotte, and B. Godeau Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine Haematologica, July 1, 2007; 92(7): e78 - e79. [Full Text] [PDF] |
||||
![]() |
A Ghavami, S Genevay, T Fulpius, and C Gabay Etanercept in treatment of Felty's syndrome Ann Rheum Dis, July 1, 2005; 64(7): 1090 - 1091. [Full Text] [PDF] |
||||

